Terms to Know: Wound Care Advancement

DMCA.com Protection Status
Blog Category: 

By the WoundSource Editors

Advanced Treatment Modalities: Wound care interventions that are typically applied when standard of care treatments have failed to lead to significant wound closure progress. Treatments include collagen products, cellular and/or tissue-based products, negative pressure wound therapy, hyperbaric oxygen, and others.

Cellular and/or Tissue-Based Products: Cellular and/or tissue-based products (CTPs) actively promote healing by stimulating the patient’s own cells to regenerate healthy tissue.

Collagen: Collagen is the most abundant protein in the human body. In wound healing, collagen attracts fibroblasts and encourages the deposition of new collagen to the wound bed.

Cytokines: Cytokines are small proteins that signal molecules that mediate and regulate immunity and inflammation.

Extracellular Matrix: The extracellular matrix (ECM) is a three-dimensional network that consists of collagen, enzymes, and glycoproteins that provide structural support to surrounding cells.

Fibroblasts: Fibroblasts synthesize the ECM and collagen and produce a structural framework that is critical in wound healing.

Hypoalbuminemia: Hypoalbuminemia is a condition in which the blood levels of albumin are low. Symptoms include fluid retention resulting in swelling, signs of jaundice, and feelings of weakness or exhaustion.

Hypoxia: Hypoxia is a condition in which a wound is deprived of adequate oxygen at the tissue level.

Keratinocytes: Keratinocytes are a major cellular component of the epidermis and are involved in the initiation, maintenance, and completion of wound healing.

Spreading Infection: Presence of proliferating bacteria outside of the wound border. May affect deep tissue, muscle fascia, organs, or body cavities.

Systemic Infection: Whole body inflammatory response. Presence of cellulitis, osteomyelitis, and/or septicemia.

Thrombospondins: A glycoprotein that contributes to linking matrix proteins and facilitating matrix organization.

The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.

Recommended for You

  • April 30th, 2021

    Approximately 2 million people in the United States are living with limb loss, and this figure is expected to double by 2050. Lower-limb amputation accounts for the vast majority of all amputations, and diabetes—specifically, diabetic foot ulcers (DFUs)—is the leading cause of nontraumatic...

  • February 11th, 2021

    By Becky Naughton, RN, MSN, FNP-C, WCC

    As a wound care nurse practitioner, when I see granulation tissue start to form on a wound, I do a little happy dance. Granulation tissue is a sign that the wound is on its way past an often-stubborn inflammatory phase of healing and...

  • September 1st, 2021

    By Steven A. Kahn, MD

    When treating severe burns, surgeons generally consider eschar removal to be the major factor and the top challenge in both initiating and planning for the optimal course of treatment for each patient. Before grafting, all devitalized tissue must be removed...

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.